

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.55402011 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.55402011 |
| 3 | glucose 6-phosphate metabolic process (GO:0051156) | 5.46057902 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.43232667 |
| 5 | tricarboxylic acid cycle (GO:0006099) | 5.34163129 |
| 6 | NADH metabolic process (GO:0006734) | 5.22109141 |
| 7 | proline biosynthetic process (GO:0006561) | 5.10101529 |
| 8 | protein maturation by protein folding (GO:0022417) | 4.91939286 |
| 9 | muscle filament sliding (GO:0030049) | 4.88809839 |
| 10 | actin-myosin filament sliding (GO:0033275) | 4.88809839 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.69042807 |
| 12 | pentose-phosphate shunt (GO:0006098) | 4.48641591 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.42156881 |
| 14 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.38199458 |
| 15 | regulation of translational fidelity (GO:0006450) | 4.32176886 |
| 16 | glutamate secretion (GO:0014047) | 4.30761289 |
| 17 | regulation of coenzyme metabolic process (GO:0051196) | 4.27102498 |
| 18 | regulation of cofactor metabolic process (GO:0051193) | 4.27102498 |
| 19 | 4-hydroxyproline metabolic process (GO:0019471) | 4.27061117 |
| 20 | * glycolytic process (GO:0006096) | 4.23155965 |
| 21 | NADPH regeneration (GO:0006740) | 4.22479027 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.20294940 |
| 23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.14975907 |
| 24 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.11559973 |
| 25 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.11205478 |
| 26 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.11205478 |
| 27 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.10416684 |
| 28 | sarcomere organization (GO:0045214) | 4.08639796 |
| 29 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.08251791 |
| 30 | oxaloacetate metabolic process (GO:0006107) | 4.05488521 |
| 31 | synaptic vesicle maturation (GO:0016188) | 4.01869851 |
| 32 | peptidyl-proline hydroxylation (GO:0019511) | 3.99042792 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.96771897 |
| 34 | cardiac muscle contraction (GO:0060048) | 3.96710717 |
| 35 | protein retention in ER lumen (GO:0006621) | 3.94962205 |
| 36 | cardiac myofibril assembly (GO:0055003) | 3.94738994 |
| 37 | glucose catabolic process (GO:0006007) | 3.86102659 |
| 38 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.85879517 |
| 39 | actin-mediated cell contraction (GO:0070252) | 3.84375195 |
| 40 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.79674614 |
| 41 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.75411568 |
| 42 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.70180243 |
| 43 | * gluconeogenesis (GO:0006094) | 3.67895573 |
| 44 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.66681344 |
| 45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.63932791 |
| 46 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.62961931 |
| 47 | cell communication by electrical coupling (GO:0010644) | 3.56443873 |
| 48 | protein hydroxylation (GO:0018126) | 3.56303988 |
| 49 | neuronal action potential propagation (GO:0019227) | 3.55424602 |
| 50 | transferrin transport (GO:0033572) | 3.55187835 |
| 51 | myofibril assembly (GO:0030239) | 3.54376944 |
| 52 | formation of translation preinitiation complex (GO:0001731) | 3.54043444 |
| 53 | vocalization behavior (GO:0071625) | 3.48777719 |
| 54 | oxidative phosphorylation (GO:0006119) | 3.47925035 |
| 55 | regulation of synaptic vesicle transport (GO:1902803) | 3.45762970 |
| 56 | plasma membrane repair (GO:0001778) | 3.44470706 |
| 57 | * striated muscle contraction (GO:0006941) | 3.43857801 |
| 58 | regulation of mitotic spindle organization (GO:0060236) | 3.43284738 |
| 59 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.43064892 |
| 60 | regulation of early endosome to late endosome transport (GO:2000641) | 3.42537962 |
| 61 | DNA unwinding involved in DNA replication (GO:0006268) | 3.42423415 |
| 62 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.40180369 |
| 63 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.39173901 |
| 64 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.38146861 |
| 65 | tricarboxylic acid metabolic process (GO:0072350) | 3.35516353 |
| 66 | regulation of skeletal muscle contraction (GO:0014819) | 3.35358526 |
| 67 | neurotransmitter secretion (GO:0007269) | 3.34872946 |
| 68 | regulation of cell communication by electrical coupling (GO:0010649) | 3.32610054 |
| 69 | * hexose biosynthetic process (GO:0019319) | 3.32347962 |
| 70 | creatine metabolic process (GO:0006600) | 3.32021521 |
| 71 | positive regulation of synapse maturation (GO:0090129) | 3.32006735 |
| 72 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.31034726 |
| 73 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.31034131 |
| 74 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.30224153 |
| 75 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.28689679 |
| 76 | proline metabolic process (GO:0006560) | 3.28538340 |
| 77 | ferric iron transport (GO:0015682) | 3.26897638 |
| 78 | trivalent inorganic cation transport (GO:0072512) | 3.26897638 |
| 79 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.25788580 |
| 80 | mitotic chromosome condensation (GO:0007076) | 3.25644915 |
| 81 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.22216560 |
| 82 | mitotic nuclear envelope reassembly (GO:0007084) | 3.21532300 |
| 83 | nuclear envelope reassembly (GO:0031468) | 3.21532300 |
| 84 | tRNA aminoacylation for protein translation (GO:0006418) | 3.20188935 |
| 85 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.19791843 |
| 86 | activation of protein kinase A activity (GO:0034199) | 3.19268135 |
| 87 | sodium ion export (GO:0071436) | 3.17779964 |
| 88 | positive regulation of nuclease activity (GO:0032075) | 3.15623905 |
| 89 | vesicle coating (GO:0006901) | 3.13015257 |
| 90 | succinate metabolic process (GO:0006105) | 3.12934576 |
| 91 | protein localization to synapse (GO:0035418) | 3.11590164 |
| 92 | locomotory exploration behavior (GO:0035641) | 3.09563427 |
| 93 | regulation of membrane repolarization (GO:0060306) | 3.08956165 |
| 94 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.07896081 |
| 95 | regulation of synapse structural plasticity (GO:0051823) | 3.07874788 |
| 96 | * pyruvate metabolic process (GO:0006090) | 3.06941551 |
| 97 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.06844934 |
| 98 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.04467520 |
| 99 | IMP biosynthetic process (GO:0006188) | 3.01654883 |
| 100 | * monosaccharide biosynthetic process (GO:0046364) | 3.01610555 |
| 101 | tRNA aminoacylation (GO:0043039) | 3.00453418 |
| 102 | amino acid activation (GO:0043038) | 3.00453418 |
| 103 | GDP-mannose metabolic process (GO:0019673) | 3.00343763 |
| 104 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.97719628 |
| 105 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.97719628 |
| 106 | cell communication involved in cardiac conduction (GO:0086065) | 2.97606363 |
| 107 | mitotic sister chromatid segregation (GO:0000070) | 2.97536954 |
| 108 | ATP synthesis coupled proton transport (GO:0015986) | 2.96650058 |
| 109 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.96650058 |
| 110 | IMP metabolic process (GO:0046040) | 2.96573179 |
| 111 | cellular potassium ion homeostasis (GO:0030007) | 2.95347149 |
| 112 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.95208862 |
| 113 | establishment of integrated proviral latency (GO:0075713) | 2.91642616 |
| 114 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.91214022 |
| 115 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.90621363 |
| 116 | regulation of relaxation of muscle (GO:1901077) | 2.89975660 |
| 117 | * glucose metabolic process (GO:0006006) | 2.89293038 |
| 118 | cardiac conduction (GO:0061337) | 2.88675218 |
| 119 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.88057370 |
| 120 | regulation of translational termination (GO:0006449) | 2.87913384 |
| 121 | actomyosin structure organization (GO:0031032) | 2.85856012 |
| 122 | membrane depolarization during action potential (GO:0086010) | 2.85166833 |
| 123 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.85114912 |
| 124 | negative regulation of potassium ion transport (GO:0043267) | 2.84522542 |
| 125 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.84365980 |
| 126 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.84278874 |
| 127 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.82821118 |
| 128 | cardiac muscle hypertrophy (GO:0003300) | 2.81145194 |
| 129 | neuron-neuron synaptic transmission (GO:0007270) | 2.80864560 |
| 130 | regulation of nuclease activity (GO:0032069) | 2.80835551 |
| 131 | cardiac muscle cell action potential (GO:0086001) | 2.80588539 |
| 132 | negative regulation of cation channel activity (GO:2001258) | 2.80214402 |
| 133 | DNA strand elongation (GO:0022616) | 2.79730864 |
| 134 | actin filament-based movement (GO:0030048) | 2.79546378 |
| 135 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.78915856 |
| 136 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.78837686 |
| 137 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.77784965 |
| 138 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.75966924 |
| 139 | * single-organism carbohydrate catabolic process (GO:0044724) | 2.75735601 |
| 140 | regulation of protein kinase A signaling (GO:0010738) | 2.75679863 |
| 141 | melanin biosynthetic process (GO:0042438) | 2.74222023 |
| 142 | ribosome assembly (GO:0042255) | 2.72141791 |
| 143 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.72045025 |
| 144 | mitochondrial genome maintenance (GO:0000002) | 2.71972017 |
| 145 | positive regulation of sodium ion transport (GO:0010765) | 2.71924414 |
| 146 | establishment of viral latency (GO:0019043) | 2.71281000 |
| 147 | pinocytosis (GO:0006907) | 2.71187669 |
| 148 | striated muscle hypertrophy (GO:0014897) | 2.70976851 |
| 149 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.70451387 |
| 150 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.70260175 |
| 151 | long-term synaptic potentiation (GO:0060291) | 2.69465458 |
| 152 | ER-nucleus signaling pathway (GO:0006984) | 2.67519053 |
| 153 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.66263668 |
| 154 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.65195949 |
| 155 | negative regulation of ligase activity (GO:0051352) | 2.63282489 |
| 156 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.63282489 |
| 157 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.61329252 |
| 158 | regulation of spindle organization (GO:0090224) | 2.60996458 |
| 159 | negative regulation of cell size (GO:0045792) | 2.59427964 |
| 160 | regulation of translational elongation (GO:0006448) | 2.59363066 |
| 161 | cellular response to unfolded protein (GO:0034620) | 2.58782818 |
| 162 | barbed-end actin filament capping (GO:0051016) | 2.58568760 |
| 163 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.57887110 |
| 164 | galactose catabolic process (GO:0019388) | 2.57391972 |
| 165 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.56892404 |
| 166 | peptidyl-arginine methylation (GO:0018216) | 2.56449699 |
| 167 | peptidyl-arginine N-methylation (GO:0035246) | 2.56449699 |
| 168 | protein complex localization (GO:0031503) | 2.56213655 |
| 169 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.56110045 |
| 170 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.55127814 |
| 171 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.53909281 |
| 172 | COPII vesicle coating (GO:0048208) | 2.53908865 |
| 173 | L-serine metabolic process (GO:0006563) | 2.52885372 |
| 174 | histone arginine methylation (GO:0034969) | 2.52175669 |
| 175 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.51977610 |
| 176 | mitotic nuclear envelope disassembly (GO:0007077) | 2.51174398 |
| 177 | * carbohydrate catabolic process (GO:0016052) | 2.50879559 |
| 178 | proteasome assembly (GO:0043248) | 2.50528610 |
| 179 | * hexose metabolic process (GO:0019318) | 2.49847287 |
| 180 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.49202296 |
| 181 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.48916428 |
| 182 | protein export from nucleus (GO:0006611) | 2.48689200 |
| 183 | * carbohydrate biosynthetic process (GO:0016051) | 2.48291855 |
| 184 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.47390279 |
| 185 | mitochondrial fusion (GO:0008053) | 2.47028443 |
| 186 | sister chromatid segregation (GO:0000819) | 2.45474242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.85477069 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.10562999 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.99937352 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.56955495 |
| 5 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.78046820 |
| 6 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.70141770 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.63338549 |
| 8 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.55698201 |
| 9 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.52944271 |
| 10 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.48523335 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.39401666 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32412525 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.31529513 |
| 14 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.28679415 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.26421877 |
| 16 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.25533626 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.19910958 |
| 18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.14117715 |
| 19 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.12925867 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.08489330 |
| 21 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.05892256 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.03469483 |
| 23 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.03238719 |
| 24 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.01769891 |
| 25 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01490766 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.00402369 |
| 27 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.96219935 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.93370356 |
| 29 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.93359915 |
| 30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.90662176 |
| 31 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.89108399 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.87747681 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.86276556 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85848508 |
| 35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82960030 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.81555722 |
| 37 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.80209489 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79096557 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.79089945 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.78158929 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77407333 |
| 42 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.76531900 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73228732 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73074312 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.70416393 |
| 46 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.68396378 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65979577 |
| 48 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65257965 |
| 49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65257965 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64707099 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.63847462 |
| 52 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63756214 |
| 53 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.63557518 |
| 54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63448679 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62947987 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61885600 |
| 57 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.61514598 |
| 58 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.61189775 |
| 59 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59049593 |
| 60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.58340406 |
| 61 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.57274920 |
| 62 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.56778136 |
| 63 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56351622 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56148654 |
| 65 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55031086 |
| 66 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.54491248 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.53039229 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.50986938 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.50163245 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46162608 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45491395 |
| 72 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.45236385 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44522571 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43927575 |
| 75 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.42887963 |
| 76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.42837447 |
| 77 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42236332 |
| 78 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41477113 |
| 79 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40841311 |
| 80 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.40048179 |
| 81 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37610392 |
| 82 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.35878934 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.35775653 |
| 84 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.34439350 |
| 85 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34140731 |
| 86 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.32556220 |
| 87 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31899413 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31766681 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30583257 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30372168 |
| 91 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29791036 |
| 92 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.28372797 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27283153 |
| 94 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25638144 |
| 95 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25304607 |
| 96 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.25052896 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.23413028 |
| 98 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.23372708 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21883623 |
| 100 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.21524090 |
| 101 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19186933 |
| 102 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.18583547 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16754671 |
| 104 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.16403821 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16094112 |
| 106 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14816375 |
| 107 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.14476316 |
| 108 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14385302 |
| 109 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.14154513 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14052680 |
| 111 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13433380 |
| 112 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12602161 |
| 113 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11715669 |
| 114 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11658848 |
| 115 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11541505 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 1.11266064 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11171197 |
| 118 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10406135 |
| 119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.10313022 |
| 120 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09426366 |
| 121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07516034 |
| 122 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07449487 |
| 123 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.07160689 |
| 124 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06977498 |
| 125 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.05551846 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05512685 |
| 127 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05022559 |
| 128 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04937827 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03615211 |
| 130 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02894278 |
| 131 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.02754469 |
| 132 | AR_19668381_ChIP-Seq_PC3_Human | 1.01362832 |
| 133 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.01336333 |
| 134 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.01192665 |
| 135 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.00511102 |
| 136 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00079937 |
| 137 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.99450626 |
| 138 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.98636953 |
| 139 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98397089 |
| 140 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98287723 |
| 141 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98181219 |
| 142 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.98064406 |
| 143 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96781552 |
| 144 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.95102395 |
| 145 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94782820 |
| 146 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94673598 |
| 147 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94527860 |
| 148 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94437032 |
| 149 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94437032 |
| 150 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92721001 |
| 151 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92439963 |
| 152 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91695831 |
| 153 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91637780 |
| 154 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.91039038 |
| 155 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90657957 |
| 156 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89968155 |
| 157 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.85522512 |
| 158 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85196402 |
| 159 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.84994447 |
| 160 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84615390 |
| 161 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.84559554 |
| 162 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84348375 |
| 163 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83511048 |
| 164 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82937366 |
| 165 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.81875375 |
| 166 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81746597 |
| 167 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.81570830 |
| 168 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81464175 |
| 169 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.81267630 |
| 170 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.81112222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.10388984 |
| 2 | MP0005451_abnormal_body_composition | 3.81049394 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.79595571 |
| 4 | MP0000751_myopathy | 3.64397923 |
| 5 | MP0003646_muscle_fatigue | 3.53060752 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.50388127 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 3.43647956 |
| 8 | MP0000749_muscle_degeneration | 3.26672949 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.02122727 |
| 10 | MP0008260_abnormal_autophagy | 2.84379252 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.83468509 |
| 12 | MP0003880_abnormal_central_pattern | 2.82421999 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.67505707 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 2.66400584 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.61910300 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.55411013 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.50632070 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.45289778 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.43590497 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.42429785 |
| 21 | MP0004270_analgesia | 2.42187895 |
| 22 | MP0009046_muscle_twitch | 2.40891210 |
| 23 | MP0003111_abnormal_nucleus_morphology | 2.33110487 |
| 24 | MP0005171_absent_coat_pigmentation | 2.32071520 |
| 25 | MP0004233_abnormal_muscle_weight | 2.30304311 |
| 26 | MP0002064_seizures | 2.26807499 |
| 27 | MP0009745_abnormal_behavioral_response | 2.24589434 |
| 28 | MP0001968_abnormal_touch/_nociception | 2.21197089 |
| 29 | MP0002736_abnormal_nociception_after | 2.14893314 |
| 30 | MP0002822_catalepsy | 2.12753906 |
| 31 | MP0002063_abnormal_learning/memory/cond | 2.08394049 |
| 32 | MP0000747_muscle_weakness | 2.06674665 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 2.02467403 |
| 34 | MP0005620_abnormal_muscle_contractility | 2.01768113 |
| 35 | MP0004087_abnormal_muscle_fiber | 1.98730428 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.97467617 |
| 37 | MP0002269_muscular_atrophy | 1.95055554 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.93773997 |
| 39 | MP0003122_maternal_imprinting | 1.92256431 |
| 40 | MP0004484_altered_response_of | 1.91165438 |
| 41 | MP0002106_abnormal_muscle_physiology | 1.89456160 |
| 42 | MP0004272_abnormal_basement_membrane | 1.80860338 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.77429570 |
| 44 | MP0008932_abnormal_embryonic_tissue | 1.77119758 |
| 45 | MP0005330_cardiomyopathy | 1.76761853 |
| 46 | MP0005408_hypopigmentation | 1.76406416 |
| 47 | MP0002734_abnormal_mechanical_nocicepti | 1.75406641 |
| 48 | MP0004858_abnormal_nervous_system | 1.72307513 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.69401671 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.67230695 |
| 51 | MP0002735_abnormal_chemical_nociception | 1.66803728 |
| 52 | MP0002572_abnormal_emotion/affect_behav | 1.66096249 |
| 53 | MP0003123_paternal_imprinting | 1.65635331 |
| 54 | MP0002272_abnormal_nervous_system | 1.64767652 |
| 55 | MP0000759_abnormal_skeletal_muscle | 1.64436427 |
| 56 | MP0008775_abnormal_heart_ventricle | 1.64421165 |
| 57 | MP0004130_abnormal_muscle_cell | 1.63997016 |
| 58 | MP0003077_abnormal_cell_cycle | 1.57886629 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.55323724 |
| 60 | MP0005369_muscle_phenotype | 1.53504916 |
| 61 | MP0008007_abnormal_cellular_replicative | 1.52354943 |
| 62 | MP0000750_abnormal_muscle_regeneration | 1.51346119 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.49367248 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.46809271 |
| 65 | MP0001730_embryonic_growth_arrest | 1.46558285 |
| 66 | MP0004085_abnormal_heartbeat | 1.45164777 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.44449773 |
| 68 | MP0009840_abnormal_foam_cell | 1.44418785 |
| 69 | MP0000003_abnormal_adipose_tissue | 1.44405500 |
| 70 | MP0006138_congestive_heart_failure | 1.44319274 |
| 71 | MP0001849_ear_inflammation | 1.41081579 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.37475165 |
| 73 | MP0004510_myositis | 1.35930720 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.35002860 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.34720331 |
| 76 | MP0005385_cardiovascular_system_phenoty | 1.34034561 |
| 77 | MP0001544_abnormal_cardiovascular_syste | 1.34034561 |
| 78 | MP0000358_abnormal_cell_content/ | 1.33522686 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.33045310 |
| 80 | MP0009672_abnormal_birth_weight | 1.31865963 |
| 81 | MP0003879_abnormal_hair_cell | 1.29974900 |
| 82 | MP0002067_abnormal_sensory_capabilities | 1.28247017 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.26679649 |
| 84 | MP0008569_lethality_at_weaning | 1.26311461 |
| 85 | MP0003329_amyloid_beta_deposits | 1.23653680 |
| 86 | MP0003137_abnormal_impulse_conducting | 1.22974094 |
| 87 | MP0003950_abnormal_plasma_membrane | 1.22431246 |
| 88 | MP0001970_abnormal_pain_threshold | 1.21870287 |
| 89 | MP0001529_abnormal_vocalization | 1.20669275 |
| 90 | MP0005386_behavior/neurological_phenoty | 1.18708432 |
| 91 | MP0004924_abnormal_behavior | 1.18708432 |
| 92 | MP0002080_prenatal_lethality | 1.18218317 |
| 93 | MP0005165_increased_susceptibility_to | 1.16330392 |
| 94 | MP0002733_abnormal_thermal_nociception | 1.16212784 |
| 95 | MP0010030_abnormal_orbit_morphology | 1.15764918 |
| 96 | MP0001661_extended_life_span | 1.14913580 |
| 97 | MP0003186_abnormal_redox_activity | 1.14206942 |
| 98 | MP0000350_abnormal_cell_proliferation | 1.13323372 |
| 99 | MP0004811_abnormal_neuron_physiology | 1.12026880 |
| 100 | MP0010630_abnormal_cardiac_muscle | 1.09405218 |
| 101 | MP0003787_abnormal_imprinting | 1.08432285 |
| 102 | MP0005375_adipose_tissue_phenotype | 1.07517503 |
| 103 | MP0005083_abnormal_biliary_tract | 1.07348905 |
| 104 | MP0005501_abnormal_skin_physiology | 1.07122208 |
| 105 | MP0002796_impaired_skin_barrier | 1.05240128 |
| 106 | MP0004381_abnormal_hair_follicle | 1.04600694 |
| 107 | MP0003786_premature_aging | 1.03696806 |
| 108 | MP0002060_abnormal_skin_morphology | 1.02839039 |
| 109 | MP0005670_abnormal_white_adipose | 1.01915452 |
| 110 | MP0005666_abnormal_adipose_tissue | 1.00871711 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.99178807 |
| 112 | MP0001486_abnormal_startle_reflex | 0.98168359 |
| 113 | MP0002653_abnormal_ependyma_morphology | 0.97103205 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.96691102 |
| 115 | MP0002184_abnormal_innervation | 0.94331647 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.94323022 |
| 117 | MP0005384_cellular_phenotype | 0.92821691 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.92682315 |
| 119 | MP0002066_abnormal_motor_capabilities/c | 0.91717037 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.90996046 |
| 121 | MP0005621_abnormal_cell_physiology | 0.90756765 |
| 122 | MP0001697_abnormal_embryo_size | 0.89211128 |
| 123 | MP0008872_abnormal_physiological_respon | 0.84539706 |
| 124 | MP0005380_embryogenesis_phenotype | 0.84402267 |
| 125 | MP0001672_abnormal_embryogenesis/_devel | 0.84402267 |
| 126 | MP0000733_abnormal_muscle_development | 0.83043508 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82215798 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.81520464 |
| 129 | MP0003011_delayed_dark_adaptation | 0.81353017 |
| 130 | MP0003121_genomic_imprinting | 0.79762333 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.78834950 |
| 132 | MP0000313_abnormal_cell_death | 0.77668085 |
| 133 | MP0004043_abnormal_pH_regulation | 0.77610071 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.76670006 |
| 135 | MP0003984_embryonic_growth_retardation | 0.76497215 |
| 136 | MP0002075_abnormal_coat/hair_pigmentati | 0.76187388 |
| 137 | MP0005623_abnormal_meninges_morphology | 0.76181801 |
| 138 | MP0005266_abnormal_metabolism | 0.75712109 |
| 139 | MP0000858_altered_metastatic_potential | 0.74221751 |
| 140 | MP0002089_abnormal_postnatal_growth/wei | 0.73967110 |
| 141 | MP0002882_abnormal_neuron_morphology | 0.73816698 |
| 142 | MP0000371_diluted_coat_color | 0.73525084 |
| 143 | MP0008877_abnormal_DNA_methylation | 0.72920761 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.72710943 |
| 145 | MP0002090_abnormal_vision | 0.70279813 |
| 146 | MP0001905_abnormal_dopamine_level | 0.70234893 |
| 147 | MP0008058_abnormal_DNA_repair | 0.69899620 |
| 148 | MP0001348_abnormal_lacrimal_gland | 0.69663136 |
| 149 | MP0002088_abnormal_embryonic_growth/wei | 0.69514483 |
| 150 | MP0002970_abnormal_white_adipose | 0.69112942 |
| 151 | MP0003633_abnormal_nervous_system | 0.69037583 |
| 152 | MP0001186_pigmentation_phenotype | 0.68080591 |
| 153 | MP0002234_abnormal_pharynx_morphology | 0.67990029 |
| 154 | MP0002557_abnormal_social/conspecific_i | 0.67794846 |
| 155 | MP0006276_abnormal_autonomic_nervous | 0.66653628 |
| 156 | MP0005423_abnormal_somatic_nervous | 0.65799619 |
| 157 | MP0004142_abnormal_muscle_tone | 0.65325180 |
| 158 | MP0000955_abnormal_spinal_cord | 0.65181984 |
| 159 | MP0002638_abnormal_pupillary_reflex | 0.64560334 |
| 160 | MP0003631_nervous_system_phenotype | 0.63020664 |
| 161 | MP0002229_neurodegeneration | 0.62724030 |
| 162 | MP0003172_abnormal_lysosome_physiology | 0.61637620 |
| 163 | MP0008874_decreased_physiological_sensi | 0.59309903 |
| 164 | MP0005646_abnormal_pituitary_gland | 0.58804533 |
| 165 | MP0000343_altered_response_to | 0.56627652 |
| 166 | MP0005535_abnormal_body_temperature | 0.54868686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 6.71752436 |
| 2 | * Abnormal gallbladder physiology (HP:0012438) | 6.01856046 |
| 3 | * Cholecystitis (HP:0001082) | 6.01856046 |
| 4 | Exercise-induced myalgia (HP:0003738) | 5.37610403 |
| 5 | Focal motor seizures (HP:0011153) | 4.75987953 |
| 6 | Myoglobinuria (HP:0002913) | 4.30295500 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 4.14867012 |
| 8 | Sudden death (HP:0001699) | 4.14165615 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.07662921 |
| 10 | Myokymia (HP:0002411) | 3.69586358 |
| 11 | Pheochromocytoma (HP:0002666) | 3.65970996 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 3.50116979 |
| 13 | Visual hallucinations (HP:0002367) | 3.46012037 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 3.43341914 |
| 15 | Atonic seizures (HP:0010819) | 3.38247884 |
| 16 | Neuroendocrine neoplasm (HP:0100634) | 3.36925938 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 3.33334512 |
| 18 | Rhabdomyolysis (HP:0003201) | 3.32871453 |
| 19 | Epileptic encephalopathy (HP:0200134) | 3.29822907 |
| 20 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.28828906 |
| 21 | Increased serum pyruvate (HP:0003542) | 3.20967107 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.20967107 |
| 23 | Myotonia (HP:0002486) | 3.17796862 |
| 24 | Focal seizures (HP:0007359) | 3.13416912 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 3.13341189 |
| 26 | Type 1 muscle fiber predominance (HP:0003803) | 3.08730929 |
| 27 | Dysmetric saccades (HP:0000641) | 3.03328755 |
| 28 | Nemaline bodies (HP:0003798) | 3.01749404 |
| 29 | Reticulocytosis (HP:0001923) | 2.95679986 |
| 30 | Resting tremor (HP:0002322) | 2.95395724 |
| 31 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.94111638 |
| 32 | * Cholelithiasis (HP:0001081) | 2.91972557 |
| 33 | Oligomenorrhea (HP:0000876) | 2.91356871 |
| 34 | Muscle stiffness (HP:0003552) | 2.89117879 |
| 35 | Distal upper limb amyotrophy (HP:0007149) | 2.87643679 |
| 36 | Upper limb amyotrophy (HP:0009129) | 2.87643679 |
| 37 | Palpitations (HP:0001962) | 2.87329362 |
| 38 | Absence seizures (HP:0002121) | 2.80009711 |
| 39 | Atrial fibrillation (HP:0005110) | 2.79452727 |
| 40 | Acute necrotizing encephalopathy (HP:0006965) | 2.75002246 |
| 41 | Distal arthrogryposis (HP:0005684) | 2.73080905 |
| 42 | Febrile seizures (HP:0002373) | 2.70419583 |
| 43 | Premature rupture of membranes (HP:0001788) | 2.70336537 |
| 44 | Subaortic stenosis (HP:0001682) | 2.70335643 |
| 45 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.70335643 |
| 46 | Generalized tonic-clonic seizures (HP:0002069) | 2.69552168 |
| 47 | Primary atrial arrhythmia (HP:0001692) | 2.69184955 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.68638661 |
| 49 | Muscle fiber splitting (HP:0003555) | 2.67370855 |
| 50 | Supraventricular tachycardia (HP:0004755) | 2.61956650 |
| 51 | Ventricular tachycardia (HP:0004756) | 2.59393932 |
| 52 | Progressive muscle weakness (HP:0003323) | 2.57519732 |
| 53 | Supraventricular arrhythmia (HP:0005115) | 2.55378088 |
| 54 | Difficulty running (HP:0009046) | 2.54079887 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.54051771 |
| 56 | Bundle branch block (HP:0011710) | 2.54018175 |
| 57 | * Abnormal gallbladder morphology (HP:0012437) | 2.53233816 |
| 58 | Abnormality of the lower motor neuron (HP:0002366) | 2.51737717 |
| 59 | Dialeptic seizures (HP:0011146) | 2.51096806 |
| 60 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.50641260 |
| 61 | Hand muscle atrophy (HP:0009130) | 2.49915090 |
| 62 | Lower limb amyotrophy (HP:0007210) | 2.46481646 |
| 63 | Increased connective tissue (HP:0009025) | 2.46049158 |
| 64 | Exercise intolerance (HP:0003546) | 2.41378149 |
| 65 | Syncope (HP:0001279) | 2.40257760 |
| 66 | Right ventricular cardiomyopathy (HP:0011663) | 2.38144308 |
| 67 | Ventricular fibrillation (HP:0001663) | 2.37591848 |
| 68 | Achilles tendon contracture (HP:0001771) | 2.37045663 |
| 69 | Hyperacusis (HP:0010780) | 2.36537078 |
| 70 | Neck muscle weakness (HP:0000467) | 2.35548481 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.34109496 |
| 72 | Shoulder girdle muscle weakness (HP:0003547) | 2.32983087 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.32727771 |
| 74 | Ventricular arrhythmia (HP:0004308) | 2.32480131 |
| 75 | Upper limb muscle weakness (HP:0003484) | 2.32392259 |
| 76 | Difficulty climbing stairs (HP:0003551) | 2.28568285 |
| 77 | Myopathic facies (HP:0002058) | 2.28359456 |
| 78 | Progressive macrocephaly (HP:0004481) | 2.27513308 |
| 79 | Insomnia (HP:0100785) | 2.27329658 |
| 80 | Ulnar deviation of the wrist (HP:0003049) | 2.27166152 |
| 81 | Increased CSF lactate (HP:0002490) | 2.26977120 |
| 82 | Mitochondrial inheritance (HP:0001427) | 2.26572210 |
| 83 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.26186703 |
| 84 | Failure to thrive in infancy (HP:0001531) | 2.25914156 |
| 85 | Left ventricular hypertrophy (HP:0001712) | 2.25749665 |
| 86 | Poor eye contact (HP:0000817) | 2.23647078 |
| 87 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.23169440 |
| 88 | Lipoatrophy (HP:0100578) | 2.22345018 |
| 89 | Hypokinesia (HP:0002375) | 2.21374472 |
| 90 | Conjunctival hamartoma (HP:0100780) | 2.19895407 |
| 91 | Hepatocellular necrosis (HP:0001404) | 2.18299217 |
| 92 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18010055 |
| 93 | Trismus (HP:0000211) | 2.17285203 |
| 94 | Spinal rigidity (HP:0003306) | 2.15825991 |
| 95 | Central scotoma (HP:0000603) | 2.14370909 |
| 96 | Round ear (HP:0100830) | 2.13121200 |
| 97 | * Abnormality of the gallbladder (HP:0005264) | 2.12769440 |
| 98 | EMG: neuropathic changes (HP:0003445) | 2.11474005 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 2.11267985 |
| 100 | Unsteady gait (HP:0002317) | 2.11193932 |
| 101 | Generalized amyotrophy (HP:0003700) | 2.10817271 |
| 102 | Prolonged QT interval (HP:0001657) | 2.10702999 |
| 103 | Distal lower limb muscle weakness (HP:0009053) | 2.10687692 |
| 104 | Ragged-red muscle fibers (HP:0003200) | 2.10403285 |
| 105 | Foot dorsiflexor weakness (HP:0009027) | 2.09046106 |
| 106 | Emotional lability (HP:0000712) | 2.06459663 |
| 107 | Depression (HP:0000716) | 2.05657887 |
| 108 | Abnormality of reticulocytes (HP:0004312) | 2.05600297 |
| 109 | Breech presentation (HP:0001623) | 2.04095297 |
| 110 | Stridor (HP:0010307) | 2.02751695 |
| 111 | Rimmed vacuoles (HP:0003805) | 2.01528970 |
| 112 | Abnormality of pain sensation (HP:0010832) | 1.99968804 |
| 113 | Impaired pain sensation (HP:0007328) | 1.99968804 |
| 114 | Cerebral hypomyelination (HP:0006808) | 1.99477671 |
| 115 | Abnormal social behavior (HP:0012433) | 1.99346403 |
| 116 | Impaired social interactions (HP:0000735) | 1.99346403 |
| 117 | Dysdiadochokinesis (HP:0002075) | 1.99195831 |
| 118 | Abnormal EKG (HP:0003115) | 1.97730859 |
| 119 | Progressive cerebellar ataxia (HP:0002073) | 1.96211260 |
| 120 | Frequent falls (HP:0002359) | 1.95371986 |
| 121 | Urinary urgency (HP:0000012) | 1.94457371 |
| 122 | Acute encephalopathy (HP:0006846) | 1.94348320 |
| 123 | Diaphragmatic weakness (HP:0009113) | 1.93114602 |
| 124 | Limb-girdle muscle atrophy (HP:0003797) | 1.92999042 |
| 125 | Distal lower limb amyotrophy (HP:0008944) | 1.91419390 |
| 126 | Abnormality of the vocal cords (HP:0008777) | 1.91395350 |
| 127 | Abnormality of the foot musculature (HP:0001436) | 1.90779949 |
| 128 | Areflexia of lower limbs (HP:0002522) | 1.89545201 |
| 129 | Hypercortisolism (HP:0001578) | 1.88795449 |
| 130 | Axonal loss (HP:0003447) | 1.87632853 |
| 131 | Fetal akinesia sequence (HP:0001989) | 1.86276585 |
| 132 | Microvesicular hepatic steatosis (HP:0001414) | 1.86028392 |
| 133 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.85970542 |
| 134 | Progressive external ophthalmoplegia (HP:0000590) | 1.82169840 |
| 135 | Impaired proprioception (HP:0010831) | 1.79904440 |
| 136 | Microglossia (HP:0000171) | 1.77715978 |
| 137 | Long palpebral fissure (HP:0000637) | 1.75803317 |
| 138 | Truncus arteriosus (HP:0001660) | 1.74788835 |
| 139 | Easy fatigability (HP:0003388) | 1.71754795 |
| 140 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.70362753 |
| 141 | Abnormality of the umbilical cord (HP:0010881) | 1.70053227 |
| 142 | Nuclear cataract (HP:0100018) | 1.69158517 |
| 143 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.68709296 |
| 144 | Distal sensory impairment (HP:0002936) | 1.67801315 |
| 145 | Abnormality of the tricuspid valve (HP:0001702) | 1.66562653 |
| 146 | Gout (HP:0001997) | 1.65218087 |
| 147 | Orthostatic hypotension (HP:0001278) | 1.64851024 |
| 148 | Hyperthyroidism (HP:0000836) | 1.62979191 |
| 149 | J-shaped sella turcica (HP:0002680) | 1.62947938 |
| 150 | Fatigue (HP:0012378) | 1.61999917 |
| 151 | Calcaneovalgus deformity (HP:0001848) | 1.60327097 |
| 152 | Ankyloglossia (HP:0010296) | 1.59821437 |
| 153 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.58730915 |
| 154 | Cerebral aneurysm (HP:0004944) | 1.57371848 |
| 155 | Protrusio acetabuli (HP:0003179) | 1.56551935 |
| 156 | Bulbar palsy (HP:0001283) | 1.56334844 |
| 157 | Increased nuchal translucency (HP:0010880) | 1.56210858 |
| 158 | Rough bone trabeculation (HP:0100670) | 1.55326829 |
| 159 | Back pain (HP:0003418) | 1.55265925 |
| 160 | Slender build (HP:0001533) | 1.54980587 |
| 161 | Hammertoe (HP:0001765) | 1.54934661 |
| 162 | Testicular atrophy (HP:0000029) | 1.52066679 |
| 163 | Pterygium (HP:0001059) | 1.51817308 |
| 164 | Elbow flexion contracture (HP:0002987) | 1.51203919 |
| 165 | Fasciculations (HP:0002380) | 1.51137371 |
| 166 | Hypertensive crisis (HP:0100735) | 1.50406272 |
| 167 | Tetraplegia (HP:0002445) | 1.50098300 |
| 168 | Type I transferrin isoform profile (HP:0003642) | 1.50004024 |
| 169 | Postnatal microcephaly (HP:0005484) | 1.49653330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 3.72410603 |
| 2 | OBSCN | 3.45147157 |
| 3 | MAP3K12 | 3.34582469 |
| 4 | NME2 | 3.08888013 |
| 5 | MAP3K9 | 2.96328155 |
| 6 | EIF2AK1 | 2.85269751 |
| 7 | BUB1 | 2.75527572 |
| 8 | SMG1 | 2.74830691 |
| 9 | NTRK3 | 2.71058829 |
| 10 | PDK3 | 2.52526047 |
| 11 | PDK4 | 2.52526047 |
| 12 | MAP3K4 | 2.49183988 |
| 13 | EEF2K | 2.43136097 |
| 14 | CASK | 2.42094532 |
| 15 | IRAK3 | 2.35111835 |
| 16 | ARAF | 2.21250470 |
| 17 | VRK2 | 2.14491879 |
| 18 | MYLK | 2.14243304 |
| 19 | ICK | 2.09906329 |
| 20 | TSSK6 | 2.09660302 |
| 21 | EPHA4 | 2.05355082 |
| 22 | DAPK1 | 1.99157073 |
| 23 | TTN | 1.97533537 |
| 24 | KSR2 | 1.93372998 |
| 25 | DAPK2 | 1.92209225 |
| 26 | MAP2K4 | 1.89325999 |
| 27 | NME1 | 1.88917048 |
| 28 | MINK1 | 1.88778275 |
| 29 | PLK2 | 1.87655485 |
| 30 | PKN2 | 1.87620413 |
| 31 | PHKG2 | 1.73283496 |
| 32 | PHKG1 | 1.73283496 |
| 33 | PAK4 | 1.68366129 |
| 34 | BCKDK | 1.67455581 |
| 35 | MST1R | 1.66463834 |
| 36 | CDK19 | 1.65166359 |
| 37 | TESK2 | 1.62750672 |
| 38 | MAP2K7 | 1.62002626 |
| 39 | SIK1 | 1.55790670 |
| 40 | PDK2 | 1.55031918 |
| 41 | DAPK3 | 1.46379122 |
| 42 | PRKD3 | 1.42165706 |
| 43 | PBK | 1.40808278 |
| 44 | LMTK2 | 1.36754987 |
| 45 | CCNB1 | 1.33954389 |
| 46 | ERN1 | 1.32432826 |
| 47 | PRPF4B | 1.28760897 |
| 48 | TTK | 1.28375851 |
| 49 | WEE1 | 1.25432550 |
| 50 | KSR1 | 1.23132836 |
| 51 | AKT3 | 1.22801704 |
| 52 | PTK2B | 1.20968540 |
| 53 | FGFR4 | 1.20715024 |
| 54 | TAOK2 | 1.18980350 |
| 55 | TRIB3 | 1.18917588 |
| 56 | LIMK1 | 1.16063563 |
| 57 | PAK6 | 1.14831537 |
| 58 | PTK2 | 1.10934076 |
| 59 | MAP3K8 | 1.10691423 |
| 60 | GRK5 | 1.08920153 |
| 61 | LATS2 | 1.03188023 |
| 62 | TESK1 | 1.02454459 |
| 63 | CAMKK1 | 0.97817344 |
| 64 | RPS6KB2 | 0.95872601 |
| 65 | STK38 | 0.92999301 |
| 66 | AKT2 | 0.92670898 |
| 67 | MAP2K1 | 0.92137375 |
| 68 | STK24 | 0.88336180 |
| 69 | RIPK4 | 0.86763148 |
| 70 | MAP3K13 | 0.86312270 |
| 71 | BRAF | 0.86154592 |
| 72 | PAK1 | 0.83705140 |
| 73 | EPHA2 | 0.81117369 |
| 74 | PRKCG | 0.81002742 |
| 75 | NTRK1 | 0.80731130 |
| 76 | EPHB1 | 0.80039209 |
| 77 | CDK18 | 0.77329757 |
| 78 | CAMKK2 | 0.77008262 |
| 79 | CDK14 | 0.75560756 |
| 80 | CDK5 | 0.74924593 |
| 81 | RAF1 | 0.74858518 |
| 82 | SGK223 | 0.74521346 |
| 83 | SGK494 | 0.74521346 |
| 84 | CAMK2A | 0.72084218 |
| 85 | CAMK1 | 0.71121611 |
| 86 | CDK15 | 0.70758332 |
| 87 | CDK7 | 0.70686254 |
| 88 | ALK | 0.70590808 |
| 89 | FER | 0.70576541 |
| 90 | MOS | 0.70110922 |
| 91 | MAP3K5 | 0.68720319 |
| 92 | PRKCH | 0.68137339 |
| 93 | SIK3 | 0.67765144 |
| 94 | MET | 0.66295019 |
| 95 | SCYL2 | 0.65903083 |
| 96 | SGK3 | 0.65295419 |
| 97 | MAPK11 | 0.64799957 |
| 98 | FLT3 | 0.61708773 |
| 99 | CAMK2D | 0.61077060 |
| 100 | SRPK1 | 0.60893201 |
| 101 | SGK2 | 0.60716290 |
| 102 | STK38L | 0.60222868 |
| 103 | LRRK2 | 0.60167005 |
| 104 | ILK | 0.60045335 |
| 105 | MAP3K11 | 0.60043924 |
| 106 | AURKA | 0.57948932 |
| 107 | CDK11A | 0.57803803 |
| 108 | BRSK1 | 0.57581049 |
| 109 | FGFR1 | 0.56186759 |
| 110 | MAP3K1 | 0.54408608 |
| 111 | BMX | 0.54387456 |
| 112 | PINK1 | 0.54251405 |
| 113 | TAOK1 | 0.54195818 |
| 114 | DMPK | 0.53585988 |
| 115 | CLK1 | 0.53374106 |
| 116 | RIPK1 | 0.52934923 |
| 117 | MAP2K3 | 0.52392954 |
| 118 | PTK6 | 0.51553979 |
| 119 | PDK1 | 0.51003730 |
| 120 | CAMK2G | 0.50738330 |
| 121 | MAP3K7 | 0.50044752 |
| 122 | MAP3K2 | 0.49585931 |
| 123 | CAMK2B | 0.49109787 |
| 124 | RET | 0.48514325 |
| 125 | MTOR | 0.48314424 |
| 126 | MAPKAPK5 | 0.47899445 |
| 127 | STK10 | 0.45338127 |
| 128 | EIF2AK3 | 0.44935334 |
| 129 | CDC42BPA | 0.44573678 |
| 130 | CDK12 | 0.43604268 |
| 131 | PDPK1 | 0.43236909 |
| 132 | MAP3K3 | 0.42919701 |
| 133 | ROCK2 | 0.41521818 |
| 134 | MAPK12 | 0.41432841 |
| 135 | PDGFRA | 0.40712756 |
| 136 | PIM2 | 0.40672760 |
| 137 | ERBB4 | 0.40324388 |
| 138 | PLK3 | 0.39528057 |
| 139 | PRKG2 | 0.39310131 |
| 140 | PAK3 | 0.38589840 |
| 141 | PRKCI | 0.38482885 |
| 142 | ROCK1 | 0.38321395 |
| 143 | PIK3CA | 0.37341398 |
| 144 | MUSK | 0.36134448 |
| 145 | MAPKAPK3 | 0.35313402 |
| 146 | AURKB | 0.33983803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.40260771 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.61229628 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.90692300 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.68432339 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.64156758 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.33237164 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.23698104 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.11184163 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.10854706 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.08176212 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.05581983 |
| 12 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.87318838 |
| 13 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.85923062 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85860126 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.85579061 |
| 16 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.84337348 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.83843714 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.83305582 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.81237947 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.79956042 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.78406014 |
| 22 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.72130681 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.70783303 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.65879655 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.59371429 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.59108132 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.56699546 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.55708424 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.50024376 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.48996271 |
| 31 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.48444859 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.47486177 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42806207 |
| 34 | Mismatch repair_Homo sapiens_hsa03430 | 1.40957169 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.40220417 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.35209815 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35080862 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.33755325 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33026315 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32957436 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.31787308 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30954123 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.30399186 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30184206 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26442873 |
| 46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.20383873 |
| 47 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.15610329 |
| 48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.14975675 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14929830 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.14409629 |
| 51 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12814278 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.11770080 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.11740794 |
| 54 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.10744114 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 1.09253245 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07881961 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 1.06523932 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03783210 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03316047 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00721074 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.98552109 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.98392717 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96888572 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96884785 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95041362 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93729379 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.93704086 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.93019621 |
| 69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91660832 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89534438 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89447595 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.89267336 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.87700370 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87414587 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85763226 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.82711708 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81767031 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81237837 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79846754 |
| 80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78918667 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.78824049 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.77056546 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.74933575 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.74666639 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73864795 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.71935183 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71553168 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71168607 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69075432 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67905158 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66058068 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.65938025 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.64559206 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63728650 |
| 95 | Tight junction_Homo sapiens_hsa04530 | 0.61490984 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.61043308 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60908590 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58570359 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58464111 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58149796 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58084101 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.57364180 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56996288 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56628443 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55839845 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52173083 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49494448 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49310779 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49121809 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.48352072 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.47845168 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47468917 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45117192 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44161813 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43341104 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42340430 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41795120 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41721873 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41230659 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41027706 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.38899234 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38009730 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37811932 |
| 124 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36947934 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36198533 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.35935692 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34433414 |
| 128 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.34310312 |
| 129 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32831989 |
| 130 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32516353 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32165240 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32066732 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30788312 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30645203 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30588972 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.30300270 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29865592 |
| 138 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.28545623 |
| 139 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28542998 |
| 140 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.28443267 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27732029 |
| 142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27455766 |
| 143 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.26567239 |
| 144 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26556554 |
| 145 | RNA polymerase_Homo sapiens_hsa03020 | 0.26470354 |
| 146 | Lysine degradation_Homo sapiens_hsa00310 | 0.26451400 |
| 147 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.26167342 |
| 148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26106177 |
| 149 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25082088 |
| 150 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24958857 |
| 151 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.24411055 |
| 152 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24393709 |

